Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chicago, Illinois 60611


Purpose:

The purpose of this study is to evaluate treatments for a rash caused by sorafenib.


Study summary:

This study will compare compare the effectiveness of four creams (urea 40% cream, fluocinonide 0.05% cream, tazarotene 0.1% cream, and Udderly smooth® Udder Cream) in treating hand-foot skin reaction, a rash caused by sorafenib.


Criteria:

Inclusion Criteria: - Patients receiving sorafenib as monotherapy or in combination if other agents are not known to cause HFSR. - Subjects must be 18 years or older. - Patients must provide written informed consent to participate in the study. - Women of childbearing potential and men must be willing to use an effective method of contraception while participating in this study and for at least two weeks after completing treatment in the study. - Women in this study need to have a negative urine pregnancy test before starting study medications. Exclusion Criteria: - Patients simultaneously taking another anti-cancer agent or combination of anti-cancer agents known to cause hand foot syndrome (pegylated doxorubicin, 5-fluorouracil, cytarabine). - Patients with an active dermatological condition due to previous chemotherapy or biologic therapy affecting the hands. - Patients with pre-existing dermatological condition affecting the hands or feet. - Women who have a positive pregnancy test or are lactating.


NCT ID:

NCT00667589


Primary Contact:

Principal Investigator
Jonathan Cotliar, MD
Northwestern University


Backup Contact:

N/A


Location Contact:

Chicago, Illinois 60611
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.